Literature DB >> 7297920

Effect of long-term treatment with cimetidine and antacids in Barrett's oesophagus.

I C Wesdorp, J Bartelsman, M E Schipper, G N Tytgat.   

Abstract

The effect of a long-term treatment (one to two years) with cimetidine (1.6 g per day) and an antacid (Regla pH) was evaluated in nine patients with a Barrett's oesophagus. The results showed that such long-term treatment had a beneficial effect on the symptoms and endoscopic signs of oesophagitis and on the healing of a Barrett's ulcer, but did not result in a regression of the squamocolumnar junction back towards the cardia. No significant changes were observed in the histological epithelial types in the biopsies taken below the squamocolumnar junction. No clinical or biochemical side-effects or changes in biochemical parameters were noted during this study.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7297920      PMCID: PMC1419878          DOI: 10.1136/gut.22.9.724

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  8 in total

1.  The histologic spectrum of Barrett's esophagus.

Authors:  A Paull; J S Trier; M D Dalton; R C Camp; P Loeb; R K Goyal
Journal:  N Engl J Med       Date:  1976-08-26       Impact factor: 91.245

2.  Multiple adenomatous neoplasms arising in columnarlined (Barrett's) esophagus.

Authors:  G B McDonald; D L Brand; D R Thorning
Journal:  Gastroenterology       Date:  1977-06       Impact factor: 22.682

3.  Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery.

Authors:  D L Brand; J T Ylvisaker; M Gelfand; C E Pope
Journal:  N Engl J Med       Date:  1980-04-10       Impact factor: 91.245

4.  The columnar-lined esophagus (Barrett syndrome)--an acquired condition?

Authors:  S M Mossberg
Journal:  Gastroenterology       Date:  1966-05       Impact factor: 22.682

5.  Barrett's esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog.

Authors:  C G Bremner; V P Lynch; F H Ellis
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

6.  Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.

Authors:  J Behar; D L Brand; F C Brown; D O Castell; S Cohen; R J Crossley; C E Pope; C S Winans
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

7.  Barrett's ulcer and treatment with cimetidine.

Authors:  T Kothari; J C Mangla; T M Kalra
Journal:  Arch Intern Med       Date:  1980-04

8.  Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas.

Authors:  A P Naef; M Savary; L Ozzello
Journal:  J Thorac Cardiovasc Surg       Date:  1975-11       Impact factor: 5.209

  8 in total
  8 in total

1.  Barrett's oesophagus.

Authors:  R C Heading
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

2.  Oesophageal function before, during, and after healing of erosive oesophagitis.

Authors:  F Baldi; F Ferrarini; A Longanesi; M Angeloni; M Ragazzini; M Miglioli; L Barbara
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

3.  Regression of Barrett's esophagus by laser ablation in an anacid environment.

Authors:  R E Sampliner; L J Hixson; M B Fennerty; H S Garewal
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

4.  Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus.

Authors:  M J Collen; D A Johnson
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

Review 5.  The neoplastic potential of columnar-lined (Barrett's) esophagus.

Authors:  G N Tytgat; W Hameeteman
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

6.  Histologic evaluation of chronic gastroesophageal reflux. An evaluation of biopsy methods and diagnostic criteria.

Authors:  T E Knuff; S B Benjamin; G F Worsham; J E Hancock; D O Castell
Journal:  Dig Dis Sci       Date:  1984-03       Impact factor: 3.199

7.  Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium.

Authors:  M W Mulholland; B J Reid; D S Levine; C E Rubin
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

8.  Lack of impact of therapy on extent of Barrett's esophagus in 67 patients.

Authors:  R E Sampliner; H S Garewal; M B Fennerty; M Aickin
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.